Global Vascular Screening Device Market Size By Type (Benchtop Vascular Screening Device, Portable Vascular Screening Device), By Application (Hospital, Ambulatory Surgical Center), By Region, And Seg...

The Global Vascular Screening Device Market was valued at USD 1.1 billion in 2023 and is projected to reach USD 2.2 billion by 2031, growing at a CAGR of 9.0% during the forecast period (2023–2031). This market is being propelled by the rising incidence of cardiovascular diseases, increased awareness regarding preventive healthcare, and growing investments in diagnostic infrastructure. Vascular screening devices—used to detect conditions such as peripheral artery disease, carotid artery disease, and abdominal aortic aneurysms—play a critical role in early disease detection, helping improve patient outcomes through timely intervention.

Drivers:

1. Growing Prevalence of Cardiovascular Diseases (CVDs):

Cardiovascular disorders remain the leading cause of death worldwide. The growing aging population, sedentary lifestyles, and unhealthy dietary habits are fueling the need for early vascular assessments, thereby boosting demand for screening devices.

2. Increasing Healthcare Awareness and Preventive Screening:

Public and private sector initiatives aimed at raising awareness about the importance of early diagnosis of vascular disorders are encouraging more individuals to undergo routine screening.

3. Technological Advancements in Diagnostic Devices:

Continuous innovations such as portable Doppler ultrasound systems, automated ankle-brachial index (ABI) devices, and AI-integrated imaging systems are improving screening efficiency and accuracy, fostering market growth.

Restraints:

1. High Cost of Advanced Screening Devices:

The high cost associated with technologically advanced vascular screening systems limits accessibility in low-income and resource-constrained regions.

2. Limited Reimbursement Policies:

In many countries, preventive screening procedures do not receive adequate reimbursement, thereby deterring patients and providers from investing in such diagnostics.

Opportunity:

1. Expansion into Emerging Economies:

Growing investments in healthcare infrastructure and increasing government support for early diagnosis in emerging markets like India, Brazil, and Southeast Asia present significant growth opportunities.

2. Integration of Artificial Intelligence (AI) and Mobile Health:

The incorporation of AI for real-time data analysis and mobile-compatible vascular screening devices offers new avenues for personalized and remote diagnostics.

Market by System Type Insights:

In 2023, the Doppler Ultrasound Segment accounted for the largest share of the market. Doppler ultrasound systems remain the gold standard for non-invasive vascular imaging due to their high precision in detecting blood flow abnormalities. Meanwhile, the Automated ABI Measurement Devices Segment is expected to exhibit the fastest growth during the forecast period, owing to increasing adoption in primary care and ambulatory settings for rapid PAD detection.

Market by End-use Insights:

Based on end use, the Hospitals and Specialty Clinics Segment dominated the market in 2023, driven by widespread usage of vascular diagnostics for inpatients and surgical candidates. However, the Diagnostic Imaging Centers Segment is projected to grow rapidly as outpatient screening programs expand in developed and developing countries alike.

Market by Regional Insights:

North America held the largest market share in 2023 due to high CVD prevalence, advanced diagnostic infrastructure, and proactive healthcare screening programs. Asia-Pacific is forecasted to be the fastest-growing region through 2031, supported by rising healthcare expenditure, increasing awareness campaigns, and expanding medical technology penetration in countries like China, India, and Indonesia.

Competitive Scenario:

Prominent players in the Global Vascular Screening Device Market include GE HealthCare, Siemens Healthineers, Koninklijke Philips N.V., Fukuda Denshi Co., Ltd., Omron Healthcare Inc., Canon Medical Systems Corporation, and Medtronic plc. These companies are emphasizing innovation, regulatory approvals, and strategic collaborations to expand their portfolios and market reach.

Key Developments:

In 2024, GE HealthCare introduced an AI-powered portable Doppler device optimized for community-based vascular screening.

In 2023, Philips launched a compact, wearable vascular monitoring system for continuous ambulatory care.

In 2022, Siemens Healthineers collaborated with major hospital networks to deploy ABI screening kits across rural North America under preventive health programs.

Scope of Work – Global Vascular Screening Device Market

Report Metric Details

Market Size (2023) USD 1.1 Billion

Projected Market Size (2031) USD 2.2 Billion

CAGR (2023–2031) 9.0%

Key Segments By System Type (Doppler Ultrasound, ABI Devices), By End-use, By Region

Growth Drivers Rising CVD prevalence, Technological innovations, Preventive healthcare demand

Opportunities AI-based diagnostics, Emerging markets, Mobile health integration

FAQs:

1) What is the current market size of the Global Vascular Screening Device Market?

The market was valued at USD 1.1 billion in 2023.

2) What is the major growth driver of the Global Vascular Screening Device Market?

The major driver is the increasing prevalence of cardiovascular diseases and the push for early, preventive healthcare diagnostics.

3) Which is the largest region during the forecast period in the Global Vascular Screening Device Market?

North America is the largest region in 2023, but Asia-Pacific is expected to grow the fastest by 2031.

4) Which segment accounted for the largest market share in the Global Vascular Screening Device Market?

The Doppler Ultrasound segment held the largest share in 2023.

5) Who are the key market players in the Global Vascular Screening Device Market?

Key players include GE HealthCare, Siemens Healthineers, Philips, Fukuda Denshi, Omron Healthcare, and Medtronic.